156 related articles for article (PubMed ID: 17347328)
1. Presence and phenotype of dendritic cells in uveal melanoma.
Polak ME; Borthwick NJ; Johnson P; Hungerford JL; Higgins B; Di Palma S; Jager MJ; Cree IA
Br J Ophthalmol; 2007 Jul; 91(7):971-6. PubMed ID: 17347328
[TBL] [Abstract][Full Text] [Related]
2. Presence and maturity of dendritic cells in melanoma lymph node metastases.
Polak ME; Johnson P; Di Palma S; Higgins B; Hurren J; Borthwick NJ; Jager MJ; Mccormick D; Cree IA
J Pathol; 2005 Sep; 207(1):83-90. PubMed ID: 15983979
[TBL] [Abstract][Full Text] [Related]
3. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163.
Woodward J; Sisley K; Reeves G; Nichols C; Parsons MA; Mudhar H; Rennie I
Int J Exp Pathol; 2004 Feb; 85(1):35-43. PubMed ID: 15113392
[TBL] [Abstract][Full Text] [Related]
4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma.
Scholes AG; Hagan S; Hiscott P; Damato BE; Grierson I
Arch Ophthalmol; 2001 Mar; 119(3):373-7. PubMed ID: 11231770
[TBL] [Abstract][Full Text] [Related]
6. Detection of M2-macrophages in uveal melanoma and relation with survival.
Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
[TBL] [Abstract][Full Text] [Related]
9. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells.
Shaif-Muthana M; McIntyre C; Sisley K; Rennie I; Murray A
Cancer Res; 2000 Nov; 60(22):6441-7. PubMed ID: 11103811
[TBL] [Abstract][Full Text] [Related]
10. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
[TBL] [Abstract][Full Text] [Related]
11. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of local immunosuppression in cutaneous melanoma.
Polak ME; Borthwick NJ; Gabriel FG; Johnson P; Higgins B; Hurren J; McCormick D; Jager MJ; Cree IA
Br J Cancer; 2007 Jun; 96(12):1879-87. PubMed ID: 17565341
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
Krishna Y; McCarthy C; Kalirai H; Coupland SE
Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
[TBL] [Abstract][Full Text] [Related]
14. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
15. HLA antigen expression on uveal melanoma cells in vivo and in vitro.
de Waard-Siebinga I; Kool J; Jager MJ
Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
[TBL] [Abstract][Full Text] [Related]
17. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
19. Effects of transpupillary thermotherapy on immunological parameters and apoptosis in a case of primary uveal melanoma.
Schurmans LR; Blom DJ; De Waard-Siebinga I; Keunen JE; Prause JU; Jager MJ
Melanoma Res; 1999 Jun; 9(3):297-302. PubMed ID: 10465586
[TBL] [Abstract][Full Text] [Related]
20. Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma.
Liang C; Peng L; Zeng S; Zhao Q; Tang L; Jiang X; Zhang J; Yan N; Chen Y
Exp Eye Res; 2019 Apr; 181():112-119. PubMed ID: 30639792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
